The malignant phenotype results from multiple genetic alterations, includin
g the activation of oncogenes and inactivation of tumor suppressor genes. A
ctivation of the Ki-ras oncogene has been implicated as an early event in t
he pathogenesis of lung adenocarcinomas in humans and experimental animal m
odels. Previous studies from this laboratory have shown that, following tre
atment of pregnant [D2 X B6D2F(1)]F-2 or Balb/c mice with the polycyclic ar
omatic hydrocarbon, 3-methylcholanthrene (MC), lung tumors from the transpl
acentally exposed offspring exhibited a high incidence of mutations in the
Ki-ras gene. The role of genetic alterations at other oncogenic or tumor su
ppressor loci that can mediate lung tumor initiation and/or progression hav
e not been well characterized in either human or murine models. Using the t
ransplacental carcinogenesis model, which results in the induction of both
lung and liver tumors following in utero exposure to NIC, the results of th
is and our previous studies show that alterations in the Ink4a locus occur
in only 15 and 27% of the lung and liver tumors, respectively. Preliminary
data also suggests that the type of mutation induced in the Ki-ras gene fol
lowing the initial exposure to MC may influence lung tumor progression. The
se results imply that damage to the Ink4a gene is not a frequent pathway to
malignant progression in mouse lung and liver tumors following in utero ex
posure to environmental carcinogens. (C) 2001 Elsevier Science Ireland Ltd.
All rights reserved.